In summary, PGC-1α may be involved in AMD pathogenesis through several mechanisms, including decreasing oxidative stress in the retina; decreasing senescence of the retinal cells; regulation of vascular endothelial growth factor (VEGF), a key target in wet AMD therapy; and improving disturbed mitochondrial functions and autophagy. Here, PPARGC1A is linked to wet macular degeneration.